Stocks
Evolent Health (EVH) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 55.7 | 43.7 | -24.8 | 84.9 | -361.3 | -321.2 | ||
| Changes by years, y/y, % | -123% | -21% | -157% | -442% | -526% | +8.4% | |||
Evolent Health. EBITDA US GAAP, bln rub
Evolent Health. EBITDA US GAAP, changes, %
Evolent Health. EBITDA US GAAP, sum by quarters, bln rub
Evolent Health (EVH) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -28.7 | 12.8 | 14.5 | -359.9 | 11.4 | -321.2 | |
| Changes by years, y/y, % | -253% | -65% | +22% | -2 809% | -140% | |||
| Changes by quarters, q/q, % | -316% | -144% | +14% | -2 577% | -103% | |||
